About NEUROLOGY16
The clinical symptoms of neurodegenerative diseases arise years after the onset of neuronal damage. By the time the patient receives a diagnosis, it might be too late to intervene and modify the advanced pathological...
The clinical symptoms of neurodegenerative diseases arise years after the onset of neuronal damage. By the time the patient receives a diagnosis, it might be too late to intervene and modify the advanced pathological state of disease. Researchers are now focusing on preventing and stopping the pathological processes in the brain at an earlier, asymptomatic state. This conference aims to disseminate cutting-edge findings on preclinical neurodegenerative diseases including Alzheimer s disease, Parkinson s disease, amyotrophic lateral sclerosis, and Huntington s disease. The event will provide a unique platform for specialists to come together across disciplines for an authoritative discussion of the methodological, regulatory, and ethical considerations of research in people at asymptomatic states of neurodegenerative disease. A high level invited oral programme, supplemented by contributed posters will provide a complete update on the latest research and thinking on the following topics: Genetic factors, cellular pathways, and neuronal vulnerability Environmental factors, epidemiology, and primary prevention Biomarkers and early diagnosis Prevention through therapeutics Trials; regulatory and ethical considerations The event will also have a translational focus, exploring genetic susceptibility, epidemiology and risk factors, neuronal vulnerability, biomarkers and early diagnosis, and disease prevention in healthy individuals with both pharmacological and non-pharmacological interventions. Attendance at this meeting will enable you to: Be part of a rich scientific programme incorporating the latest developments in preclinical neurodegenerative diseases Understand the shift towards prevention and early diagnosis of neurodegenerative disease as the future of research in the field Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice. Network with speakers and other leading experts across disciplines. Using Elsevier's new NEUROLOGY16 app, you can browse the scientific programme by days, topic or speaker, create your own personal programme, locate rooms and exhibitor stands on the floor plans, and more. Before first use, you will need to download the latest conference data and then afterwards, you can use the app offline.
Requires iOS 7.1 or later. Compatible with iPhone, iPad, and iPod touch.
Previous Versions
Here you can find the changelog of NEUROLOGY16 since it was posted on our website on 2016-12-28 02:49:20.
The latest version is 1.0 and it was updated on 2024-04-19 21:59:10. See below the changes in each version.
NEUROLOGY16 version 1.0
Updated At: 2016-09-26
Disclaimer
Official App Store Link
We do not host NEUROLOGY16 on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Apple and passed their terms and conditions to be listed there. We recommend caution when installing it.
The App Store link for NEUROLOGY16 is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
